• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. International Journal of Pharmacology
  2. Vol 13 (7), 2017
  3. 818-831
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

International Journal of Pharmacology

Year: 2017 | Volume: 13 | Issue: 7 | Page No.: 818-831
DOI: 10.3923/ijp.2017.818.831

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 199

Authors


Mohammed Hussen Bule


Ishtiaq Ahmed

Country: Pakistan

Faheem Maqbool


Muhammad Anjum Zia


Keywords


  • malaria
  • Plasmodium falciparum
  • drug discovery
  • active compounds
  • Quinazolinone
Review Article

Quinazolinone Derivatives as a Potential Class of Compounds in Malaria Drug Discovery

Mohammed Hussen Bule, Ishtiaq Ahmed, Faheem Maqbool and Muhammad Anjum Zia
Malaria causes over a million deaths each year (2 percent of the global total of deaths), with hundreds of millions of clinical episodes per annum. The greatest challenge to malaria control and eradication is the emergence of malaria parasites that are resistant to antimalarial drugs. The development of resistance to conventionally used anti-malarial drugs, such as chloroquine (CQ) and Sulfadoxine-Pyrimethamine (SP) has been documented. To counter this WHO recommended that artemisinin-based combination therapy (ACT) should be used for treating uncomplicated Plasmodium falciparum malaria to ensure efficacy and reduce the emergence of drug-resistant parasites. Currently available antimalarial drugs are ineffective and their number is declining because of the widespread resistance. Thus, the new antimalarial agent is in urgent demand; however, the development of new antimalarial drug presents challenges due to resistance, toxicity, minimal efficacy of those on the pipeline and high cost of drug research. Identification of novel drug targets and design of new chemical compounds acting on new targets is important to control the emergence of resistance to existing drugs. In this regard, a natural product derived synthetic analogs of febrifugine containing quinazolinone scaffold can be considered best. Therefore, quinazolinones are potential compounds in seeking for novel drugs that act against the malarial pathogen. Hence, in this review compounds containing quinazolinone structure and possessing antimalarial activities are covered.
PDF Fulltext XML References Citation

How to cite this article

Mohammed Hussen Bule, Ishtiaq Ahmed, Faheem Maqbool and Muhammad Anjum Zia, 2017. Quinazolinone Derivatives as a Potential Class of Compounds in Malaria Drug Discovery. International Journal of Pharmacology, 13: 818-831.

DOI: 10.3923/ijp.2017.818.831

URL: https://scialert.net/abstract/?doi=ijp.2017.818.831

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved